Research Articles

Minimum costs to manufacture new treatments for COVID-19.

Hill A, Wang J, Levi J, Heath K, Fortunak J

COVID-19

Five-year Changes in Methamphetamine Use, Dependence, and Remission in a Community-recruited Cohort.

Lanyon C, Nambiar D, Higgs P, Dietze P, Quinn B

Assessment of service refinement and its impact on repeat HIV testing by client's access to Australia's universal healthcare system: a retrospective cohort study.

Ryan KE, Wilkinson AL, Asselin J, Leitinger DP, Locke P, Pedrana A, Hellard M, Stoové M

Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis.

Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Wilson D, Jani I, Apollo T, Sculpher M, Hallett T, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams B, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Barnabas R, Ayles H, Meyer-Rath G, Nelson L, Johnson C, Baggaley R, Fakoya A, Jahn A, Revill P

Bacterial and fungal infections in COVID-19 patients: A matter of concern.

Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan XG

COVID-19

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine.

Center RJ, Boo I, Phu L, McGregor J, Poumbourios P, Drummer HE